Group One Trading
SMMT icon

Group One Trading’s Summit Therapeutics SMMT Stock Holding History

Group One Trading’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Sell
114,400
-54,200
-32% -$877K ﹤0.01% 1999
2025
Q4 		$2.95M Sell
168,600
-36,600
-18% -$689K 0.01% 1931
2025
Q3 		$4.24M Buy
205,200
+39,400
+24% +$955K 0.01% 1619
2025
Q2 		$3.53M Buy
165,800
+33,200
+25% +$757K 0.01% 1611
2025
Q1 		$2.56M Sell
132,600
-124,500
-48% -$2.5M 0.01% 1606
2024
Q4 		$4.59M Sell
257,100
-106,800
-29% -$2.07M 0.01% 1231
2024
Q3 		$7.97M Buy
363,900
+254,800
+234% +$3.56M 0.02% 719
2024
Q2 		$851K Buy
109,100
+94,600
+652% +$511K ﹤0.01% 2135
2024
Q1 		$60K Sell
14,500
-7,400
-34% -$29.4K ﹤0.01% 4564
2023
Q4 		$57.2K Sell
21,900
-31,100
-59% -$64K ﹤0.01% 4950
2023
Q3 		$99.1K Sell
53,000
-47,900
-47% -$91.3K ﹤0.01% 4465
2023
Q2 		$253K Sell
100,900
-94,600
-48% -$173K ﹤0.01% 3692
2023
Q1 		$342K Buy
195,500
+13,200
+7% +$36K ﹤0.01% 3136
2022
Q4 		$775K Buy
+182,300
New +$332K ﹤0.01% 2640
2022
Q1 		– Sell
-1,100
Closed -$3K – 8651
2021
Q4 		$3K Sell
1,100
-700
-39% -$3.37K ﹤0.01% 7809
2021
Q3 		$9K Buy
1,800
+1,000
+125% +$7.18K ﹤0.01% 7562
2021
Q2 		$6K Buy
+800
New +$5.25K ﹤0.01% 7715

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Group One Trading's SMMT Position: Q1 2026 in Review

Group One Trading increased its Summit Therapeutics (SMMT) stake by 36% in Q1 2026, buying an estimated $184K and bringing the position to 42,781 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

Group One Trading first reported a position in SMMT in Q4 2018 and has held it in 19 quarters since. The position peaked at $4.09M in Q3 2024. 222 funds tracked by Wall St. Rank hold SMMT as of Q1 2026.

  • Group One Trading held 42,781 shares of Summit Therapeutics worth $811K as of Q1 2026.
  • Group One Trading bought 11,371 Summit Therapeutics shares in Q1 2026, an estimated $184K.
  • Summit Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2907 holding.
  • Group One Trading first reported a position in Summit Therapeutics in Q4 2018 and has held it in 19 quarters since.
  • Group One Trading's Summit Therapeutics position peaked at $4.09M in Q3 2024.
  • 222 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.